Active, Not Recruiting A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. NCT05335993 Conditions Adenocarcinoma of Ovary, Adnexal Diseases, Carcinoma, +25 more Locations Duke Cancer Center — Durham, North Carolina, United States Stephenson Cancer Center- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States University of Virginia Health System — Charlottesville, Virginia, United States View Trial Details
